The 36-month beta value for RGC is at -0.58. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 as “hold,” and 1 as “sell.”
The public float for RGC is 12.02M, and currently, shorts hold a 0.07% of that float. The average trading volume for RGC on October 11, 2024 was 199.60K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RGC) stock’s latest price update
Regencell Bioscience Holdings Ltd (NASDAQ: RGC)’s stock price has plunge by 31.13relation to previous closing price of 5.26. Nevertheless, the company has seen a 41.98% surge in its stock price over the last five trading sessions. globenewswire.com reported 2024-09-30 that ROANOKE, Va., Sept. 30, 2024 (GLOBE NEWSWIRE) — The Board of Directors of RGC Resources, Inc. (NASDAQ: RGCO), at its meeting on September 30, 2024, declared a quarterly dividend of $0.20 per share on the Company’s common stock. The dividend will be paid on November 1, 2024 to shareholders of record on October 18, 2024. This is the Company’s 322nd consecutive quarterly cash dividend.
RGC’s Market Performance
Regencell Bioscience Holdings Ltd (RGC) has experienced a 41.98% rise in stock performance for the past week, with a 12.75% rise in the past month, and a 100.00% rise in the past quarter. The volatility ratio for the week is 30.15%, and the volatility levels for the past 30 days are at 17.06% for RGC. The simple moving average for the last 20 days is 23.39% for RGC stock, with a simple moving average of -12.42% for the last 200 days.
RGC Trading at -2.75% from the 50-Day Moving Average
After a stumble in the market that brought RGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.73% of loss for the given period.
Volatility was left at 17.06%, however, over the last 30 days, the volatility rate increased by 30.15%, as shares surge +23.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.35% lower at present.
During the last 5 trading sessions, RGC rose by +41.98%, which changed the moving average for the period of 200-days by -56.05% in comparison to the 20-day moving average, which settled at $5.59. In addition, Regencell Bioscience Holdings Ltd saw -34.29% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for RGC
The total capital return value is set at -0.43. Equity return is now at value -37.93, with -36.20 for asset returns.
Based on Regencell Bioscience Holdings Ltd (RGC), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 3.32.
Currently, EBITDA for the company is -5.5 million with net debt to EBITDA at 0.25.
Conclusion
In conclusion, Regencell Bioscience Holdings Ltd (RGC) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
